The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
- PMID: 34455946
- DOI: 10.2174/1574884716666210427115820
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
Abstract
Background: It has been recognized that patients should be involved in the design of clinical trials. However, there is a lack of agreement on what patient-centricity means.
Methods: In this article, a Patient Motivation Pyramid based on Maslow's theory of human motivation is introduced as a tool to identify patient needs. This pyramid is used to make a comprehensive overview of options to implement a patient-centric trial design. The Pyramid with the described options can help to identify patient-centric activities suitable for given drug development. The current article further describes the potential benefits of patient-centric trial designs with an emphasis on early clinical development. Especially in early clinical development, during which trials have many assessments per patient, and the safety and clinical efficacy are uncertain, patient-centric trial design can improve feasibility. Finally, we present three case examples on patient-centric trial design. The first example is seeking patient input on the trial design for a First-in-Human trial which includes patients with Immune Thrombocytopenic Purpura. The second example is the use of a video-link for home dosing. The final example is the use of digital medicine in a decentralized trial in heart failure patients.
Results: A comprehensive overview of patients' needs can be accomplished by building a Patient Motivation Pyramid as a tool. Patient input can lead to improved endpoints, improved feasibility, better recruitment, less dropout, less protocol amendments, and higher patient satisfaction. The use of digital medicine can lead to a trial design with much less visits to the clinical research center in early clinical development and in a later development phase, even to a complete virtual trial.
Conclusion: We recommend using the Patient Motivation Pyramid as a structural approach for identifying elements of patient-centricity. Secondly, we recommend starting using patient-centric approaches in an early phase of the medicine's lifecycle.
Keywords: Patient-centric; decentralized trial; early clinical development; home-based; patient motivation pyramid; survey.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations.J Pharm Sci. 2023 Apr;112(4):922-936. doi: 10.1016/j.xphs.2023.01.029. Epub 2023 Feb 3. J Pharm Sci. 2023. PMID: 36739904 Review.
-
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges.Pharmaceut Med. 2024 Mar;38(2):109-120. doi: 10.1007/s40290-024-00518-x. Epub 2024 Mar 7. Pharmaceut Med. 2024. PMID: 38453755 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Role of health plan administrative claims data in participant recruitment for pragmatic clinical trials: An Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) example.Clin Trials. 2020 Apr;17(2):212-222. doi: 10.1177/1740774520902989. Epub 2020 Feb 3. Clin Trials. 2020. PMID: 32009464
-
Toward a theory of holistic needs and the brain.Holist Nurs Pract. 2011 Sep-Oct;25(5):258-65. doi: 10.1097/HNP.0b013e31822a0301. Holist Nurs Pract. 2011. PMID: 21832931
Cited by
-
Healthy participant engagement in early clinical trials: results from the European EUFEMED survey.Front Pharmacol. 2025 Aug 1;16:1540948. doi: 10.3389/fphar.2025.1540948. eCollection 2025. Front Pharmacol. 2025. PMID: 40822492 Free PMC article.
-
Systemic Responses Towards Oxy-Inflammation, Hormones, and Mood in Breast Cancer Survivors: Preliminary Evidences from Dragon Boat Endurance Race.J Clin Med. 2025 Apr 7;14(7):2532. doi: 10.3390/jcm14072532. J Clin Med. 2025. PMID: 40217981 Free PMC article.
-
Improving Trial Informativeness: A Rapid Review of Global Research on How to Ensure Trials Are Useful.J Eval Clin Pract. 2025 Jun;31(4):e70147. doi: 10.1111/jep.70147. J Eval Clin Pract. 2025. PMID: 40499566 Free PMC article. Review.
-
Who should be included in first-in-human trials? A systematic review of reasons.J Transl Med. 2025 Jun 11;23(1):649. doi: 10.1186/s12967-025-06550-y. J Transl Med. 2025. PMID: 40500760 Free PMC article.
-
Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review.BMJ Open. 2024 Nov 24;14(11):e082096. doi: 10.1136/bmjopen-2023-082096. BMJ Open. 2024. PMID: 39581733 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources